• Startseite
  • Aktien
  • Arena Pharmaceuticals Aktie

    • Arena Pharmaceuticals

    41,09 $ -3,45% -1,47 $
    In Euro: 36,347 € | 14.12.18 22:00:00 Uhr Nasdaq | Mehr Kurse »
    WKN: A2DR4A
    ISIN: US0400476075
    US-Symbol: ARNA
    Typ: Aktie
    Arena Pharmaceuticals Aktie Chart

    Performance Arena Pharmaceuticals Aktie

      
    1 Woche 1 Monat 3 Monate Lfd. Jahr 1 Jahr 3 Jahre
    Kurs 40,55 $ 32,52 $ 42,18 $ 33,97 $ 30,28 $ 17,30 $
    Änderung +1,33% +26,35% -2,58% +20,96% +35,70% +137,51%

    Nachrichten zur Arena Pharmaceuticals Aktie

      
    26.11.18 Arena Pharmaceuticals Expands Senior Management Team to Support Commercialization and Medical Affairs PR Newswire
    20.11.18 Arena Pharmaceuticals to Participate in Upcoming Investor Conferences PR Newswire
    15.11.18 Arena Pharmaceuticals and United Therapeutics Announce Global License Agreement for Ralinepag PR Newswire
    13.11.18 Arena Pharmaceuticals Presented Preclinical Data for APD418 in Development for Treatment of Decompensated Heart Failure at American Heart Association Scientific Sessions PR Newswire
    07.11.18 Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2018 Financial Results PR Newswire
    31.10.18 Arena Pharmaceuticals to Release Third Quarter 2018 Financial Results and Provide Corporate Update on November 7 PR Newswire

    Forum zur Arena Pharmaceuticals Aktie

      
    4
    ARNA - Arena Pharmaceuticals
    183 Beiträge
    Vassago: ARNA 40,93$ (+26%)
    15.11.18
    Lizenzvereinbarung mit United Therapeuticshttp://invest.arenapharm.com/news-​releases/news-​release-details/arena-​pharmaceuticals-and-united-therapeutics-announce-global
     
    ARENA: show down am 14. September
    2 Beiträge
    Magnetfeldfre.: Arena die nächste Dendreon?
    02.09.10
    Der Showdown, genauer das Panel sind am 169.2010 und die FDA Entscheidung am 22.10.2010!

    Analysen

      
    Kaufen Halten Verkaufen
    Analysten 0 0 0
    Markt-Lotsen 0 0 0

    Aktie & Unternehmen

      
    Branche Pharmazie
    Herkunft USA
    Website www.arenapharm.com
    Indizes/Listen NASDAQ
    Aktienanzahl 49,2 Mio. (Stand: 25.06.18)
    Marktkap. 2,02 Mrd. $

    Dividenden & Splits

      
    19.06.17 Reverse Split 10:1

    Ähnliche Aktien

      
    Name
    last
    change_rel
     
    Palatin Technologies 0,64 € -1,54%
    Albireo Pharma 20,78 € -3,53%
    Johnson & Johnson 117,03 € -10,10%
    Cannabis Science 0,032 € +3,23%
    Gilead Sciences 57,90 € -2,16%